申请人:Japan Tobacco Inc.
公开号:US20140187534A1
公开(公告)日:2014-07-03
A compound of the following general formula [I]:
wherein each symbol has the same meaning as defined herein, or a pharmaceutically acceptable salt thereof, or a solvate thereof, and a pharmaceutical use of the same in treating organ transplant rejection, graft versus host reaction after transplantation, autoimmune disease, allergic disease and chronic myeloproliferative disease.
下列通式[I]的化合物:
其中,每个符号的含义与此处定义的相同,或其药学上可接受的盐,或其溶剂化物;以及将其用于治疗器官移植排斥、移植后移植物抗宿主反应、自身免疫性疾病、过敏性疾病和慢性增生性疾病的药物用途。